---
title: "Hezong Medicine Easy-To-Buy Pharmaceutical: Net profit loss of 742,100 yuan in the third quarter, a decrease of 140.42%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262425785.md"
description: "Hezong Medicine Easy-To-Buy Pharmaceutical announced that its revenue for the third quarter was 1.085 billion yuan, a year-on-year increase of 7.41%; net profit loss was 742,100 yuan, a decrease of 140.42%. Revenue for the first three quarters was 3.242 billion yuan, a year-on-year increase of 0.21%; net profit loss was 8.3565 million yuan, a decrease of 159.98%"
datetime: "2025-10-23T11:49:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262425785.md)
  - [en](https://longbridge.com/en/news/262425785.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262425785.md)
---

# Hezong Medicine Easy-To-Buy Pharmaceutical: Net profit loss of 742,100 yuan in the third quarter, a decrease of 140.42%

Hezong Medicine Easy-To-Buy Pharmaceutical announced that its revenue for the third quarter was 1.085 billion yuan, an increase of 7.41% year-on-year; the net profit loss was 742,100 yuan, a decrease of 140.42%. Revenue for the first three quarters was 3.242 billion yuan, an increase of 0.21% year-on-year; the net profit loss was 8.3565 million yuan, a decrease of 159.98%

### Related Stocks

- [300937.CN](https://longbridge.com/en/quote/300937.CN.md)

## Related News & Research

- [REG - Dekel Agri-Vision - Director Dealings](https://longbridge.com/en/news/295517875.md)
- [Rocket Sharing says Mexedia completes purchase of 51% stake in Stantup Service](https://longbridge.com/en/news/295563109.md)
- [VentriPoint targets shift to subscription-based access for VMS+ cardiac imaging platform](https://longbridge.com/en/news/295684428.md)
- [OpenAI Hits the Brakes on Astra AI After Model Raises ‘Critical’ Cyberattack Risk](https://longbridge.com/en/news/295507976.md)
- [Talks advance for consortium to buy Liverpool stake](https://longbridge.com/en/news/295414537.md)